Cholera News and Research

Latest Cholera News and Research

Group Health helps protect public from infectious diseases through nationwide network

A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units (VTEUs), has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.

27 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Researchers discover how Yersinia immobilizes immune system to spread within organs

Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.

17 Sep 2013

Annual treated wastewater in North America roughly equals volume of Niagara Falls; less than 4% is reused

Amid growing competition for freshwater from industry and cities, coupled with a rising world shortage of potash, nitrogen and phosphorus, an international study predicts a rapid increase in the use of treated wastewater for farming and other purposes worldwide.

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

New techniques for predicting severity of seasonal cholera epidemics

In two recently published papers, Tufts University School of Engineering researchers have established new techniques for predicting the severity of seasonal cholera epidemics months before they occur and with a greater degree of accuracy than other methods based on remote satellite imaging.

16 Aug 2013

Study highlights challenges of predicting disease outcomes in warming world

Climate change is already affecting the spread of infectious diseases--and human health and biodiversity worldwide--according to disease ecologists reporting research results in this week's issue of the journal Science.

13 Aug 2013

Researchers uncover evidence that genetic changes play role in resistance to deadly disease

Researchers have long understood that genetics can play a role in how susceptible people are to contracting cholera, but a team of Harvard scientists is now uncovering evidence of genetic changes that might also help protect some people from contracting the deadly disease.

20 Jul 2013

Study identifies genomic regions associated with cholera susceptibility

An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.

4 Jul 2013

Researchers discover role of TonB bacterial protein that causes various diseases

A Kansas State University-led study has discovered the role of a protein in bacteria that cause a wide variety of diseases, including typhoid fever, plague, meningitis and dysentery. The results may lead to new and improved antibiotics for humans and animals.

2 Jul 2013

Study reveals strain of V. cholerae in Haiti cholera outbreak originated from single source

The strain of cholera that has sickened thousands in Haiti came from a single source and was not repeatedly introduced to the island over the past three years as some have thought, according to a new study published in mBio-, the online open-access journal of the American Society for Microbiology.

2 Jul 2013

Study explores potential of satellite remote sensing data on the occurrence of cholera

Cholera remains one of the most prevalent water-related infections in many tropical regions of the world, specifically coastal areas of South Asia, Africa, and Latin America. We now know how to treat cholera patients, and hence mortality for cholera has considerably decreased in several parts of the globe.

4 Jun 2013

Experts from ProfNet are available to discuss hurricane preparedness and response

With hurricane season on its way, here are experts from the ProfNet network that are available to discuss hurricane preparedness and response for consumers and businesses. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing.

1 Jun 2013

Saint Louis University extends search for new medicines to treat childhood diarrhea

A $750,000 grant to the Center for World Health and Medicine at Saint Louis University will extend the search for new medicines to treat childhood diarrhea, which is the second leading cause of death of young children worldwide.

1 Jun 2013

New study provides clear picture of the impact and causes of diarrheal diseases

A new international study published today in The Lancet provides the clearest picture yet of the impact and most common causes of diarrheal diseases, the second leading killer of young children globally, after pneumonia.

14 May 2013

Collaborative research network to understand spread of infectious diseases

The Models of Infectious Disease Agent Study is a collaborative research network funded by the National Institutes of Health that uses computational, statistical and mathematical models to understand the spread of infectious diseases such as influenza, pertussis, West Nile disease, dengue fever and cholera.

30 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Study suggests strain with Haiti cholera mutations may increase severity of disease

The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera, reports a new Northwestern Medicine study.

17 Apr 2013

Misconduct by Zimbabwe U.N. official might have worsened 2008 cholera outbreak, U.N. tribunal finds

South Africa's Mail & Guardian examines the findings of a recent U.N. tribunal that found misconduct by the former head of the U.N. Development Programme office in Zimbabwe, which led to the 2009 wrongful dismissal of the head of the U.N.'s Office for the Coordination of Humanitarian Affairs after he warned about the potential for a cholera epidemic.

17 Apr 2013

Cholera epidemic in Haiti expected to worsen with onset of rainy season, lack of funds

"Nearly 2.5 years after it began, Haiti's cholera epidemic is getting worse, not better, and efforts to treat the sick are desperately short of funds, say aid groups on the ground," The Lancet reports.

15 Apr 2013

Cholera News and Research

Latest Cholera News and Research

Group Health helps protect public from infectious diseases through nationwide network

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Researchers discover how Yersinia immobilizes immune system to spread within organs

Annual treated wastewater in North America roughly equals volume of Niagara Falls; less than 4% is reused

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

New techniques for predicting severity of seasonal cholera epidemics

Study highlights challenges of predicting disease outcomes in warming world

Researchers uncover evidence that genetic changes play role in resistance to deadly disease

Study identifies genomic regions associated with cholera susceptibility

Researchers discover role of TonB bacterial protein that causes various diseases

Study reveals strain of V. cholerae in Haiti cholera outbreak originated from single source

Study explores potential of satellite remote sensing data on the occurrence of cholera

Experts from ProfNet are available to discuss hurricane preparedness and response

Saint Louis University extends search for new medicines to treat childhood diarrhea

New study provides clear picture of the impact and causes of diarrheal diseases

Collaborative research network to understand spread of infectious diseases

Edible malarial vaccine may work against other viral and bacterial infections

Study suggests strain with Haiti cholera mutations may increase severity of disease

Misconduct by Zimbabwe U.N. official might have worsened 2008 cholera outbreak, U.N. tribunal finds

Cholera epidemic in Haiti expected to worsen with onset of rainy season, lack of funds

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cholera News and Research

Latest Cholera News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in